These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2373827)

  • 1. In vivo delineation of myocardial hypoxia during coronary occlusion using fluorine-18 fluoromisonidazole and positron emission tomography: a potential approach for identification of jeopardized myocardium.
    Shelton ME; Dence CS; Hwang DR; Herrero P; Welch MJ; Bergmann SR
    J Am Coll Cardiol; 1990 Aug; 16(2):477-85. PubMed ID: 2373827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial kinetics of fluorine-18 misonidazole: a marker of hypoxic myocardium.
    Shelton ME; Dence CS; Hwang DR; Welch MJ; Bergmann SR
    J Nucl Med; 1989 Mar; 30(3):351-8. PubMed ID: 2738664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive detection of hypoxic myocardium using fluorine-18-fluoromisonidazole and positron emission tomography.
    Martin GV; Caldwell JH; Graham MM; Grierson JR; Kroll K; Cowan MJ; Lewellen TK; Rasey JS; Casciari JJ; Krohn KA
    J Nucl Med; 1992 Dec; 33(12):2202-8. PubMed ID: 1460516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced binding of the hypoxic cell marker [3H]fluoromisonidazole in ischemic myocardium.
    Martin GV; Caldwell JH; Rasey JS; Grunbaum Z; Cerqueira M; Krohn KA
    J Nucl Med; 1989 Feb; 30(2):194-201. PubMed ID: 2738648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delineation of hypoxia in canine myocardium using PET and copper(II)-diacetyl-bis(N(4)-methylthiosemicarbazone).
    Lewis JS; Herrero P; Sharp TL; Engelbach JA; Fujibayashi Y; Laforest R; Kovacs A; Gropler RJ; Welch MJ
    J Nucl Med; 2002 Nov; 43(11):1557-69. PubMed ID: 12411560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac emission computed tomography: underestimation of regional tracer concentrations due to wall motion abnormalities.
    Parodi O; Schelbert HR; Schwaiger M; Hansen H; Selin C; Hoffman EJ
    J Comput Assist Tomogr; 1984 Dec; 8(6):1083-92. PubMed ID: 6334106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of fluorine-18-fluorodeoxyglucose and tritiated fluoromisonidazole uptake during low-flow ischemia.
    Caldwell JH; Revenaugh JR; Martin GV; Johnson PM; Rasey JS; Krohn KA
    J Nucl Med; 1995 Sep; 36(9):1633-8. PubMed ID: 7658224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of thallium-201 redistribution versus glucose uptake as predictors of viability after coronary occlusion and reperfusion.
    Melin JA; Wijns W; Keyeux A; Gurné O; Cogneau M; Michel C; Bol A; Robert A; Charlier A; Pouleur H
    Circulation; 1988 Apr; 77(4):927-34. PubMed ID: 3349587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose.
    Bonow RO; Dilsizian V; Cuocolo A; Bacharach SL
    Circulation; 1991 Jan; 83(1):26-37. PubMed ID: 1984883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of salvage of reperfused ischemic myocardium by diltiazem.
    Knabb RM; Rosamond TL; Fox KA; Sobel BE; Bergmann SR
    J Am Coll Cardiol; 1986 Oct; 8(4):861-71. PubMed ID: 3489747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoromisonidazole. A metabolic marker of myocyte hypoxia.
    Martin GV; Cerqueira MD; Caldwell JH; Rasey JS; Embree L; Krohn KA
    Circ Res; 1990 Jul; 67(1):240-4. PubMed ID: 2364494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of iodovinylmisonidazole as a marker for myocardial hypoxia.
    Martin GV; Biskupiak JE; Caldwell JH; Rasey JS; Krohn KA
    J Nucl Med; 1993 Jun; 34(6):918-24. PubMed ID: 8509858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal dependence of beneficial effects of coronary thrombolysis characterized by positron tomography.
    Bergmann SR; Lerch RA; Fox KA; Ludbrook PA; Welch MJ; Ter-Pogossian MM; Sobel BE
    Am J Med; 1982 Oct; 73(4):573-81. PubMed ID: 6981998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new 18F-labeled myocardial PET tracer: myocardial uptake after permanent and transient coronary occlusion in rats.
    Higuchi T; Nekolla SG; Huisman MM; Reder S; Poethko T; Yu M; Wester HJ; Casebier DS; Robinson SP; Botnar RM; Schwaiger M
    J Nucl Med; 2008 Oct; 49(10):1715-22. PubMed ID: 18794259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early recovery of regional performance in salvaged ischemic myocardium following coronary artery occlusion in the dog.
    Darsee JR; Kloner RA; Braunwald E
    J Clin Invest; 1981 Jul; 68(1):225-39. PubMed ID: 7019244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relation between myocardial perfusion, myocardial necrosis and residual glucose metabolism as a vitality parameter in the post-ischemic myocardium following coronary reperfusion].
    Sochor H
    Acta Med Austriaca Suppl; 1989; 39():1-36. PubMed ID: 2787948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial thallium-201 kinetics during coronary occlusion and reperfusion: influence of method of reflow and timing of thallium-201 administration.
    Granato JE; Watson DD; Flanagan TL; Gascho JA; Beller GA
    Circulation; 1986 Jan; 73(1):150-60. PubMed ID: 3940665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomography demonstrates that coronary sinus retroperfusion can restore regional myocardial perfusion and preserve metabolism.
    O'Byrne GT; Nienaber CA; Miyazaki A; Araujo L; Fishbein MC; Corday E; Schelbert HR
    J Am Coll Cardiol; 1991 Jul; 18(1):257-70. PubMed ID: 2050930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative assessment of prolonged metabolic abnormalities in reperfused canine myocardium.
    Buxton DB; Mody FV; Krivokapich J; Phelps ME; Schelbert HR
    Circulation; 1992 May; 85(5):1842-56. PubMed ID: 1572040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of fluoromisonidazole binding in stroke.
    Spratt NJ; Ackerman U; Tochon-Danguy HJ; Donnan GA; Howells DW
    Stroke; 2006 Jul; 37(7):1862-7. PubMed ID: 16763190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.